Signatope
Stage
Seed VC | AliveTotal Raised
$670KLast Raised
$670K | 5 yrs agoAbout Signatope
Signatope develops protein assays that are capable of detecting and quantifying biomarkers for organ damage and drug interactions in blood, urine and tissue. In addition, Signatope offers analytical services for clients in the pharmaceutical and chemical industries.
Signatope Headquarter Location
Markwiesenstr. 55
Reutlingen, D-72770,
Germany
+49 7121 51530802
Expert Collections containing Signatope
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Signatope is included in 2 Expert Collections, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Omics
1,265 items
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Latest Signatope News
Sep 25, 2018
Premium NEW YORK (GenomeWeb) – Protein analytics firm Signatope is applying its amino acid motif-specific antibody technology to identifying and measuring protein biomarkers for drug development. Get the full story with GenomeWeb Premium
Where is Signatope's headquarters?
Signatope's headquarters is located at Markwiesenstr. 55, Reutlingen.
What is Signatope's latest funding round?
Signatope's latest funding round is Seed VC.
How much did Signatope raise?
Signatope raised a total of $670K.
Who are the investors of Signatope?
Investors of Signatope include High-Tech Grunderfonds.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.